Sit, Stay, and Heal: Bringing Precision Medicine to Dogs, then Humans

December 10, 2024

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

ImpriMed is working to deliver on the promise of precision medicine by using a patient’s live cancer cells to see how they respond to different treatment options and artificial intelligence to predict which medicines will work best. The company has had impressive results with its customers to date, but the catch is that it has initially targeted its service to the veterinary market, and its dogs and cats have benefited from it. The company is now working to bring its offering to two-legged patients. We spoke to Sungwon Lim, CEO of ImpriMed, about its functional precision medicine and AI platform to match cancer patients to the best available therapy for them, its decision to roll out the service first to the veterinary market, and what it is doing to bring its service to humans.

Video/Podcast Interviews

AI, Cancer & the Future of Pet Care with Dr Ilona Holcomb

The Pets Mag Podcast
Learn More →

From Dogs to Humans: The Power of Precision Medicine with Dr. Lim

Target Cancer Podcast
Learn More →

Personalized Medicine in Veterinary Oncology

Veterinary Innovation Podcast
Learn More →

Interview with Dr. Sungwon Lim, CEO of ImpriMed

Innovating with Scott Amyx
Learn More →

Tech Founder Interview with Sungwon Lim, CEO & Founder of ImpriMed

Tech Founder Show by Insivia
Learn More →

Which Drugs Can Kill Your Dog's Cancer Cells? - ImpriMed's Sungwon Lim | Canine Cancer Rebel

Canine Cancer Alliance
Learn More →

Interview with Sungwon Lim: Founder & CEO of ImpriMed

Entrepreneurship, Interviews, Level Up!
Learn More →